✦ LIBER ✦

Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery

✍ Scribed by K. Kanellakopoulou; H. Giamarellou; P. Papadothomakos; H. Tsipras; J. Chloroyiannis; R. Theakou; P. Sfikakis

Publisher: Springer
Year: 1993
Tongue: English
Weight: 545 KB
Volume: 12
Category: Article
ISSN: 0934-9723
DOI: 10.1007/bf01967440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meropenem-monotherapy versus imipenem/ci

Meropenem-monotherapy versus imipenem/cilastatin in the treatment of severe hospital-acquired infections at ICU

✍ U. Hartenauer; S. Kljucar; H. -J. Bender; S. Weilemann; H. Nußer; K. F. Bodmann 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 60 KB

Prospective, randomised, multicentre stu

Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections

✍ J. Garau; J. Blanquer; L. Cobo; S. Corcia; M. Daguerre; F. J. de Latorre; C. Leó 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 726 KB

Cost-utility analysis comparing meropene

Cost-utility analysis comparing meropenem with imipenem plus cilastatin in the treatment of severe infections in intensive care

✍ Steven J. Edwards; Helen E. Campbell; Jonathan M. Plumb 📂 Article 📅 2006 🏛 Springer 🌐 French ⚖ 840 KB

Randomized multicenter clinical trial wi

Randomized multicenter clinical trial with imipenem/cilastatin versus cefotaxime/gentamicin in the treatment of patients with non-life-threatening infections

📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 999 KB

How should imipenem-cilastatin be Used i

How should imipenem-cilastatin be Used in the treatment of fever and infection in neutropenic cancer patients?

✍ Issam I. Raad; Dima Abi-Said; Kenneth V. Rolston; Cynthia L. Karl; Gerald P. Bod 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## Background: Imipenem-cilastatin (referred to hereafter as imipenem) is administered at different doses as monotherapy or with other agents. limited comparisons of the alternatives exist. the authors compared the efficacy and safety of several imipenem-containing regimens (icrs) to determine the